PlainRecalls
FDA Drug Moderate Class II Terminated

Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03

Reported: September 21, 2022 Initiated: September 13, 2022 #D-1536-2022

Product Description

Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03

Reason for Recall

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Details

Units Affected
11,802 1000-count bottles
Distribution
Product was distributed to major distributors/wholesalers nationwide.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 11,802 1000-count bottles.
Why was this product recalled?
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 21, 2022. Severity: Moderate. Recall number: D-1536-2022.